Apnimed, Inc. (APMD)
NASDAQ: APMD · Real-Time Price · USD
22.85
-1.05 (-4.41%)
Sep 30, 2026, 11:06 AM EDT - Market open
Apnimed Employees
Apnimed had 81 employees as of June 30, 2026.
Employees
81
Change
n/a
Growth
n/a
Revenue / Employee
$1,421,235
Profits / Employee
$2,019,543
Market Cap
951.06M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 81 | - | - |
| Mar 31, 2026 | 65 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Ardelyx | 489 |
| Kura Oncology | 260 |
| Alumis | 239 |
| Rigel Pharmaceuticals | 174 |
| Sana Biotechnology | 142 |
| Cullinan Therapeutics | 109 |
| Cybin | 100 |
| SpyGlass Pharma | 76 |
APMD News
- 21 days ago - Apnimed Reports Second Quarter 2026 Financial Results and Provides Corporate Update - GlobeNewsWire
- 22 days ago - Apnimed Quarterly report: Q2 2026 - Filings
- 22 days ago - Apnimed Earnings release: Q2 2026 - Filings
- 25 days ago - Apnimed, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 5 weeks ago - Apnimed initiated with an Overweight at Cantor Fitzgerald - TheFly
- 5 weeks ago - Apnimed initiated with an Overweight at Cantor Fitzgerald - TheFly
- 5 weeks ago - Apnimed initiated with an Outperform at Evercore ISI - TheFly
- 5 weeks ago - Apnimed initiated with an Outperform at LifeSci Capital - TheFly